Assignee
GILEAD CONNECTICUT INC
US·18 granted patents·4 pending applications·251 citations·filing 2013–2018
Top patents by PatentIndex Score
22 records- 0197US9120811B26-(1H-indazol-6-YL)-N-(4-morpholinophenyl)imidazo[1,4-A]pyrazin-8-amine for treating leukemia or lymphomaGILEAD CONNECTICUT INC·Filed 2014·Granted Sep 1, 2015·28 cites·10 claims
- 0297US8765761B26-(1H-indazol-6-yl)-N-{4-[2-methyl-1-(morpholin-4-yl)propan-2-yl]phenyl}imidazo[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a syk inhibitorGILEAD CONNECTICUT INC·Filed 2013·Granted Jul 1, 2014·29 cites·7 claims
- 0396US8796270B2N-[6-(1H-indazol-6-yl)imidazo[1,2-A]pyridin-8-yl]-6-(morpholin-4-yl)pyridazin-3-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitorGILEAD CONNECTICUT INC·Filed 2013·Granted Aug 5, 2014·25 cites·7 claims
- 0496US8748607B2Imidazopyrizine syk inhibitorsGILEAD CONNECTICUT INC·Filed 2013·Granted Jun 10, 2014·34 cites·13 claims
- 0595US9796718B26-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amineGILEAD CONNECTICUT INC·Filed 2015·Granted Oct 24, 2017·14 cites·2 claims
- 0695US9567348B2Substituted pyrazolo[1,5-a]pyrimidines as Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2015·Granted Feb 14, 2017·15 cites·2 claims
- 0795US9212191B26-(2,3-dihydro-1H-pyrido-[2,3-b][1,4]oxazin-7-yl)-N-(4-morpholinophenyl)imidazo[1,2-a] pyrazin-8-amine as a spleen tyrosine kinase inhibitorGILEAD CONNECTICUT INC·Filed 2014·Granted Dec 15, 2015·19 cites·7 claims
- 0894US8962835B2Imidazopyrazine Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2013·Granted Feb 24, 2015·22 cites·8 claims
- 0991US9382256B2Formulation of Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2014·Granted Jul 5, 2016·17 cites·57 claims
- 1089US10093684B2Substituted imidazo[1,2-a]pyrazines as Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2017·Granted Oct 9, 2018·5 cites·10 claims
- 1188US10092583B2Imidazopyridines Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2016·Granted Oct 9, 2018·5 cites·19 claims
- 1288US9949932B2Formulation of syk inhibitorsGILEAD CONNECTICUT INC·Filed 2016·Granted Apr 24, 2018·8 cites·14 claims
- 1388US9657023B2Polymorph of Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2014·Granted May 23, 2017·12 cites·9 claims
- 1487US10266539B2Polymorph of Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2017·Granted Apr 23, 2019·7 cites·19 claims
- 1585US9918939B2Formulation of Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2014·Granted Mar 20, 2018·8 cites·23 claims
- 1680US9505785B2Pyridone and aza-pyridone compounds and methods of useGILEAD CONNECTICUT INC·Filed 2013·Granted Nov 29, 2016·3 cites·37 claims
- 1764US2018086769A1Imidazopyrazine syk inhibitorsGILEAD CONNECTICUT INC·Filed 2017·Application pending·0 cites
- 1863US10344040B2Pyridone and aza-pyridone compounds and methods of useGILEAD CONNECTICUT INC·Filed 2018·Granted Jul 9, 2019·0 cites·16 claims
- 1956US10053469B2Pyridone and aza-pyridone compounds and methods of useGILEAD CONNECTICUT INC·Filed 2016·Granted Aug 21, 2018·0 cites·27 claims
- 2050US2013267496A1Imidazopyrazine syk inhibitorsGILEAD CONNECTICUT INC·Filed 2013·Application pending·0 cites
- 2150US2017217967A1Polymorph of syk inhibitorsGILEAD CONNECTICUT INC·Filed 2017·Application pending·0 cites
- 2243US2013338142A1Imidazopyrazine syk inhibitorsGILEAD CONNECTICUT INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GILEAD CONNECTICUT INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →